Profile for Taiwan Patent: 201030010
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Taiwan Patent: 201030010
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Jun 8, 2030 | Viiv Hlthcare | TIVICAY PD | dolutegravir sodium |
| ⤷ Start Trial | Jun 8, 2030 | Viiv Hlthcare | TRIUMEQ PD | abacavir sulfate; dolutegravir sodium; lamivudine |
| ⤷ Start Trial | Jun 8, 2030 | Viiv Hlthcare | DOVATO | dolutegravir sodium; lamivudine |
| ⤷ Start Trial | Jun 8, 2030 | Viiv Hlthcare | JULUCA | dolutegravir sodium; rilpivirine hydrochloride |
| ⤷ Start Trial | Jun 8, 2030 | Viiv Hlthcare | TIVICAY | dolutegravir sodium |
| ⤷ Start Trial | Jun 8, 2030 | Viiv Hlthcare | TRIUMEQ | abacavir sulfate; dolutegravir sodium; lamivudine |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
